- Harrow to Attend 2024 ASRS Annual Meeting
- Harrow Enters into 340B Prime Vendor Program Contract with Apexus™ for IHEEZO® and Other Key Harrow Products
- Harrow Provides TRIESENCE® Relaunch Update
- Melt Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 Program of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery
- Harrow Announces 52-Week Data from VEVYE® ESSENCE-2 Open-Label Extension Study
- Harrow to Present at Two Investor Conferences in May
- Harrow Announces First Quarter 2024 Financial Results
- Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial
- Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
More ▼
Key statistics
On Tuesday, Harrow Inc (HROW:NMQ) closed at 24.24, -5.23% below its 52-week high of 25.58, set on Jul 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 25.00 |
---|---|
High | 25.44 |
Low | 24.22 |
Bid | 24.24 |
Offer | 24.26 |
Previous close | 25.28 |
Average volume | 328.04k |
---|---|
Shares outstanding | 35.38m |
Free float | 30.40m |
P/E (TTM) | -- |
Market cap | 894.46m USD |
EPS (TTM) | -0.9079 USD |
Data delayed at least 15 minutes, as of Jul 23 2024 20:51 BST.
More ▼